Our Opinion

Cel-Sci Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Evidence:

CEL-SCI’s other immunotherapy platform technology L.E.A.P.S.** (Ligand Epitope Antigen Presentation System), or LEAPS, currently has multiple investigational therapies in various stages of development, primarily at the pre-clinical stage (in animal studies).

CEL-2000 was tested in a well established animal model of rheumatoid arthritis and compared to Enbrel®, a leading treatment for people with rheumatoid arthritis.

CEL-SCI has operations in Vienna, Virginia and Baltimore, Maryland. CEL-SCI’s other products, which are currently in pre-clinical stage, have shown protection against a number of diseases in animal tests and are being tested against diseases associated with bio-defense

Company Description

CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases. [Source: MarketWatch]

Company website: http://www.cel-sci.com